Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 3 22Phase 1 7Phase NA 5Phase 4 4Phase 1/2 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Sexuality 1Osteoporosis 1Neoplasms, Hormone-Dependent 1Fractures, Bone 1Bone Diseases, Metabolic 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Aromatase Inhibitors × Clear all
NCT05362760 2025-05-16

MINERVA

University of Ulm

Phase 4 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT03111615 2017-12-05

HOTBreast

Centro Hospitalar Lisboa Ocidental

Phase 4 Unknown
90 enrolled

Neoplasms, Hormone-Dependent

NCT02467686 2017-03-20

Cimicifuga

Irmandade da Santa Casa de Misericordia de Sao Paulo

Phase 4 Unknown
60 enrolled

Sexuality

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡